Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Japanese researchers describe amidine compounds for eating disorders

Jan. 29, 1999

Nippon Soda discloses new series of inhibitors of cholesterol biosynthesis

Jan. 29, 1999

Another lipid-lowering statin now on the market in Argentina

Jan. 28, 1999

SB patents new cathepsin K inhibitors

Jan. 28, 1999

Widely used herbal antiobesity agent tested in randomized, controlled trial

Jan. 27, 1999

Another market introduction for Lilly's SERM

Jan. 27, 1999

Livial not available in Germany for osteoporosis prevention

Jan. 27, 1999

Potent ACAT inhibitors for lipid disorders from Sankyo

Jan. 27, 1999

Amylin reports additional data from long-term pramlintide studies

Jan. 27, 1999

Japanese authorities approve Viagra

Jan. 26, 1999

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...